| Repurposing Vandetanib plus Everolimus for the Treatment of ACVR1-Mutant Diffuse Intrinsic Pontine GliomaVandetanib and Everolimus in ACVR1-Mutant DIPG DM Carvalho, PJ Richardson, N Olaciregui, R Stankunaite, C Lavarino, ... Cancer discovery 12 (2), 416-431, 2022 | 28 | 2022 |
| Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells M Berlak, E Tucker, M Dorel, A Winkler, A McGearey, E Rodriguez-Fos, ... Molecular Cancer 21 (1), 1-19, 2022 | 25 | 2022 |
| Circulating tumour DNA sequencing to determine therapeutic response and identify tumour heterogeneity in patients with paediatric solid tumours R Stankunaite, SL George, L Gallagher, S Jamal, R Shaikh, L Yuan, ... European Journal of Cancer 162, 209-220, 2022 | 14 | 2022 |
| Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study O Ruhen, NSM Lak, J Stutterheim, SG Danielli, M Chicard, Y Iddir, ... JCO Precision Oncology 6, e2100534, 2022 | 11 | 2022 |
| Liquid biopsy for children with central nervous system tumours: Clinical integration and technical considerations R Stankunaite, LV Marshall, F Carceller, L Chesler, M Hubank, SL George Frontiers in Pediatrics, 2057, 2022 | 5 | 2022 |
| Molecular profiling of cell free DNA in patients with paediatric solid tumours R Stankunaite Institute of Cancer Research (University Of London), 2023 | | 2023 |
| CORRELATION WITH DISEASE BURDEN AND EARLY DETECTION OF RECURRENCE USING A NOVEL NUCLEOSOME-BASED PLASMA BASED ASSAY IN LONGITUDINALLY MONITORED NEUROBLASTOMA PATIENTS LR Portela, C Himsworth, R Stankunaite, J Micallef, G Barone, C Duncan, ... PEDIATRIC BLOOD & CANCER 69, 2022 | | 2022 |
| CELL FREE DNA MOLECULAR PROFILING IDENTIFIES TARGETABLE ALTERATIONS IN PAEDIATRIC CANCER PATIENTS AT RELAPSE R Stankunaite, S George, D Hughes, A Brew, C Lynn, P Proszek, ... PEDIATRIC BLOOD & CANCER 69, 2022 | | 2022 |
| EXTH-46. ARTIFICIAL INTELLIGENCE-BASED IDENTIFICATION OF COMBINED VANDETANIB AND EVEROLIMUS IN THE TREATMENT OF ACVR1-MUTANT DIFFUSE INTRINSIC PONTINE GLIOMA D Carvalho, P Richardson, NG Olaciregui, R Stankunaite, CE Lavarino, ... Neuro-oncology 22 (Supplement_2), ii97-ii97, 2020 | | 2020 |
